Effects of diode laser with and without a desensitizing agent in the treatment of dentinal hypersensitivity

Phase 3

Completed

Registration Number: CTRI/2022/03/041381

Lead Sponsor: A

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Patients who are cooperative, motivated and willing to participate in the study will be included.

2. Patients who will be having sensitive teeth that show abrasion, erosion or gingival recession with exposure of cervical dentin.

3. Patients having good systemic health with clinically elicitable dentinal hypersensitivity who will be reliable in their response to test measurements.

4. Patients who will be willing and available for recall follow ups.

5. Patients with no known allergies to commercial dental products.

6. History of no use of desensitizing toothpaste or mouthwash past 3 months.

7. Patients who have not received any professional desensitizing therapy for dentinal

hypersensitivity in the past 3 months.

8. Patients who will be having minimum 1 and maximum 32 hypersensitive teeth will be included in the study.

Exclusion Criteria

1.Patients having deep dental caries or large restorations on the selected hypersensitive teeth.

2. Patients who will be having cracked or chipped teeth with hypersensitivity.

3. Patients with cervical restorations or premature contacts on the hypersensitive teeth.

4. Patients who will be having chronic disease with daily pain episodes, and on any analgesics / antiâ??inflammatory, anticonvulsive, anti-histaminic, tranquilizing or sedative medication drugs in the last 72 hours.

5.Patients who are lactating or are pregnant women .

6. Patients with any cardio-circulatory disease or having cardio pacemaker.

7. Patients with the habit of smoking or alcohol intake.

8.Patients who will not consent to participate or to attend the follow up recall appointments.

9.Excessive dietary or environmental exposure to acids.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome will be mean pain reduction <br/ ><br>The discomfort / pain will be recorded by VISUAL ANALOG SCALE (VAS) and VERBAL RATING SCALE(VRS) <br/ ><br>Tactile test and air blast stimulus recordings will be assessed at baseline- before treatment , 15 minutes after treatment, 7th day,14th day,30th day and 90th day after treatment. <br/ ><br>Timepoint: Primary outcome will be mean pain reduction <br/ ><br>The discomfort / pain will be recorded by VISUAL ANALOG SCALE (VAS) and VERBAL RATING SCALE(VRS)Tactile test and air blast stimulus recordings will be assessed at baseline- before treatment , 15 minutes after treatment, 7th day,14th day,30th day and 90th day after treatment. <br/ ><br> <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
Plaque index, Gingival indexTimepoint: Assessment will be done at baseline i.e. before treatment, at 7th day , 14th day , 30th day and on 90th day after treatment